Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats

M. M. Misro; Sankar P. Chaki; Shankar P. Chaki; Mahesh Kaushik; Deoki Nandan

doi:10.1016/j.contraception.2009.01.003

Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats

M. M. Misro, Sankar P. Chaki, Shankar P. Chaki, Mahesh Kaushik, Deoki Nandan

In: Contraception · 2009 · vol. 79(6) , pp. 488–497 · doi:10.1016/j.contraception.2009.01.003 · PMID:19442786 · W2027814373

article OA: closed CC0 ⤵ 2 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reports on trials of a once-a-month injectable male contraceptive combining dienogest and testosterone undecanoate, detailing dose standardization, efficacy, and reversibility in rat studies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (2)

References (43)

Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men via openalex
Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men via openalex
doi:10.1002/j.1939-4640.2002.tb02311.x via openalex
W91045939 via openalex
doi:10.1210/jcem.87.2.8218 via openalex
doi:10.1093/humrep/17.11.2869 via openalex
doi:10.1002/ar.1091870307 via openalex
doi:10.1210/jc.2004-1852 via openalex
doi:10.1002/j.1939-4640.1998.tb02011.x via openalex
doi:10.1016/j.tips.2003.11.009 via openalex
doi:10.1093/humrep/17.6.1490 via openalex
doi:10.1210/jc.2003-030574 via openalex
doi:10.1210/jc.2002-020447 via openalex
doi:10.1111/j.1365-2605.1990.tb01048.x via openalex
doi:10.1093/humupd/dml010 via openalex
doi:10.1046/j.1365-2265.2000.01024.x via openalex
doi:10.1210/endo.140.9.6958 via openalex
doi:10.1007/s10495-005-0813-7 via openalex
doi:10.1210/jc.2003-031307 via openalex
doi:10.1002/ar.1090940210 via openalex
doi:10.1016/s0039-128x(03)00135-1 via openalex
doi:10.1016/0010-7824(92)90161-l via openalex
doi:10.1016/s0015-0282(00)01490-4 via openalex
doi:10.1111/j.1365-2605.2003.00431.x via openalex
doi:10.1007/s10495-006-8761-4 via openalex
doi:10.1210/jcem.81.2.8636300 via openalex
doi:10.1093/humrep/dei300 via openalex
doi:10.1016/s0010-7824(02)00390-6 via openalex
doi:10.1210/jc.2003-030107 via openalex
doi:10.1210/endo-57-3-369 via openalex
doi:10.1016/0010-7824(87)90020-5 via openalex
doi:10.1210/jc.2003-030616 via openalex
doi:10.1038/ncpendmet0069 via openalex
doi:10.1016/s0010-7824(97)00142-x via openalex
doi:10.1210/jcem.87.8.8710 via openalex
doi:10.1210/jc.87.8.3562 via openalex
doi:10.1210/en.140.9.3938 via openalex
doi:10.1016/s0015-0282(16)58221-1 via openalex
doi:10.1210/jc.87.2.530 via openalex
doi:10.1016/0140-6736(90)92416-f via openalex
doi:10.1002/j.1939-4640.2000.tb03272.x via openalex
doi:10.1210/jc.81.2.757 via openalex
doi:10.1046/j.1365-2265.2000.01097.x via openalex

Cited by (2)

Source provenance

openalex: last seen: 2026-05-11T06:20:36.346967+00:00
unpaywall: last seen: 2026-06-16T06:25:30.133384+00:00

License: CC0 · commercial use OK

[1] Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men 2002

[2] Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men 2002